Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Retained Earnings (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Retained Earnings readings, the most recent being $523.3 million for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 3078623.53% to $523.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $523.3 million, a 3078623.53% increase, with the full-year FY2025 number at $474.2 million, up 740818.75% from a year prior.
  • Retained Earnings hit $523.3 million in Q1 2026 for Catalyst Pharmaceuticals, up from $474.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $523.3 million in Q1 2026 to a low of -$453000.0 in Q1 2022.
  • Median Retained Earnings over the past 5 years was $21500.0 (2022), compared with a mean of $103.1 million.
  • Biggest five-year swings in Retained Earnings: crashed 906.67% in 2022 and later surged 3078623.53% in 2026.
  • Catalyst Pharmaceuticals' Retained Earnings stood at $24000.0 in 2022, then tumbled by 41.67% to $14000.0 in 2023, then surged by 357.14% to $64000.0 in 2024, then skyrocketed by 740818.75% to $474.2 million in 2025, then increased by 10.37% to $523.3 million in 2026.
  • The last three reported values for Retained Earnings were $523.3 million (Q1 2026), $474.2 million (Q4 2025), and $446.8 million (Q3 2025) per Business Quant data.